Author: Lisa Gillepsie

Drug Company Gilead Gives $11M To Halt Hep C Rise In Ohio Valley

This article was originally published by Ohio Valley ReSource. Drug maker Gilead Sciences will give $11.3 million to help prevent and treat hepatitis C in Kentucky, Indiana, West Virginia, Tennessee and North Carolina. That money is part of a five-year project aimed at a region that’s been hit hard by the viral disease. About 43,000 […]

Read More